Balrampur Chini Mills
Balrampur Chini Mills
Consumer GoodsKey Fundamentals
MicrocapSugarConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company's working capital requirements have reduced from 43.8 days to 21.8 days
Weaknesses
5- Stock is trading at 3.17 times its book value
- The company has delivered a poor sales growth of 5.44% over past five years.
- Company has a low return on equity of 11.0% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 14.6% of profits over last 3 years
Growth Rate
AI Analysis — Bull vs Bear
Balrampur Chini Mills has a market capitalisation of about Rs 14,461 crore and trades at 38.4x earnings and 3.1x book value. TTM sales grew 15% while TTM profit fell 11%, and 5-year profit growth is -4%. Return on equity has slipped from a 10-year average of 17% to 11% over 3 years and 10% last year, even as the stock has gained 48% over the past year.
- Working capital requirements have fallen from 43.8 days to 21.8 days. That points to better inventory and receivables management in a business that holds a lot of sugar inventory.
- Top-line momentum has picked up. TTM sales growth of 15% is well above the 3-year sales CAGR of 10% and the 5-year CAGR of 5%.
- Over the long run, the stock has compounded at a 20% CAGR over 10 years and returned 48% over the past year. The market has rewarded the company's shift toward distillery and ethanol.
- Profit grew at a 10% CAGR over 3 years, matching 3-year sales growth. Margins held up over that period despite the cyclical nature of sugar.
- The 10-year ROE average of 17% shows the business has earned higher returns in better parts of the sugar and ethanol cycle. The current 10-11% may partly reflect where the cycle stands.
- Revenue has grown at a 9% CAGR over 10 years, a fairly steady record for a commodity-linked sugar business with diversified ethanol and power streams.
- Dividend yield is 0.52% and the payout ratio has been 14.6% over 3 years. The high retention of earnings leaves internal funds for capacity growth and new ventures.
- At a P/E of 38.4x, the valuation is high for a business whose TTM profit fell 11% and whose 5-year profit CAGR is -4%.
- Returns on capital have been falling. ROE has moved from a 10-year average of 17% to 12% over 5 years, 11% over 3 years and 10% last year.
- Sales growth over five years has been weak at 5.44%, which puts the recent 15% TTM growth in the context of a slow long-term trend.
- Price-to-book is about 3.1-3.28x while ROE is only 10-11%. That gap means investors are already pricing in a meaningful recovery in returns.
- The company may be capitalising interest cost. If so, reported profit could look better than the underlying economics, and the full interest burden may only show up once projects are commissioned.
- Stock returns were 13% CAGR over 5 years and 15% over 3 years, well below the 48% gained in the last year. Much of the recent rally is concentrated in a short window.
- The 0.52% dividend yield and 14.6% payout over 3 years give shareholders little cash return, even though the company has a long profitable history.
- Profit has lagged sales over 10 years, growing at a 5% CAGR against 9% for sales. That suggests the business has not been able to scale margins through the cycle.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹75 crore BioE3 grant for PLA Sep 24
DBT-BIRAC awarded ₹75 crore under the BioE3 initiative to fund a 100 TPA PLA co-polymer R&D facility in Kumbhi, Uttar Pradesh. It complements the company's ongoing 80,000 TPA commercial PLA plant and strengthens its bio-based materials diversification beyond sugar.
- ESG 'Leader' rating of 72 Sep 18
SEBI-registered provider Niche99 assigned an ESG score of 72, classified as 'Leader'. The voluntary assessment was based on publicly available information and may support appeal to ESG-focused investors.
- ₹200 crore CP repaid on time Sep 23
The company fully repaid ₹100 crore of commercial paper on Sep 18, 2026 (ISIN INE119A14898) and another ₹100 crore on Sep 23, 2026, both on schedule. Timely servicing of short-term debt points to sound liquidity management.
- ₹3.50 final dividend approved Sep 16
The 50th AGM on Sep 16, 2026 approved a final dividend of ₹3.50 per share. Shareholders also reappointed key directors and approved acceptance of the BIRAC grant assistance.
TL;DR: Balrampur Chini's recent news is mostly constructive. The ₹75 crore BioE3 grant and the 80,000 TPA PLA project strengthen its push into bioplastics, and the ESG 'Leader' rating adds to its credibility. On-time repayment of ₹200 crore in commercial paper and a ₹3.50 dividend point to steady finances, though these articles don't address core sugar-cycle risks such as cane pricing, export policy or ethanol realisations. The trend looks stable to improving, and how well the PLA plant is executed and commissioned will be the main thing to watch for a rerating.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,390 | 1,539 | 1,230 | 1,434 | 1,422 | 1,298 | 1,192 | 1,504 | 1,542 | 1,671 | 1,454 | 1,604 | 1,637 |
| Expenses | 1,226 | 1,375 | 1,117 | 1,090 | 1,255 | 1,249 | 1,068 | 1,138 | 1,408 | 1,550 | 1,252 | 1,319 | 1,523 |
| Operating Profit | 163 | 165 | 113 | 345 | 166 | 49 | 124 | 365 | 134 | 120 | 202 | 285 | 114 |
| OPM % | 12% | 11% | 9% | 24% | 12% | 3.8% | 10% | 24% | 9% | 7% | 14% | 18% | 7% |
| Other Income | 18 | 116 | 60 | 12 | 15 | 73 | 16 | 20 | 16 | 18 | 17 | 22 | 21 |
| Interest | 34 | 17 | 8 | 25 | 36 | 20 | 7 | 30 | 34 | 14 | 4 | 26 | 32 |
| Depreciation | 41 | 41 | 42 | 43 | 43 | 43 | 44 | 43 | 44 | 44 | 44 | 45 | 44 |
| PBT | 107 | 223 | 123 | 289 | 102 | 59 | 89 | 312 | 73 | 80 | 171 | 236 | 59 |
| Tax % | 31% | 25% | 26% | 30% | 31% | -14% | 21% | 26% | 29% | 33% | 34% | 32% | 25% |
| Net Profit | 74 | 166 | 91 | 203 | 70 | 67 | 70 | 229 | 52 | 54 | 113 | 160 | 44 |
| EPS in Rs | 3.64 | 8.24 | 4.53 | 10.08 | 3.48 | 3.33 | 3.49 | 11.35 | 2.55 | 2.67 | 5.62 | 7.9 | 2.09 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,987 | 2,757 | 3,460 | 4,343 | 4,286 | 4,741 | 4,812 | 4,846 | 4,666 | 5,594 | 5,415 | 6,271 | 6,366 |
| Expenses | 2,859 | 2,342 | 2,557 | 3,888 | 3,595 | 4,059 | 4,098 | 4,139 | 4,144 | 4,808 | 4,705 | 5,525 | 5,645 |
| Operating Profit | 128 | 414 | 903 | 454 | 691 | 682 | 714 | 707 | 522 | 786 | 711 | 747 | 721 |
| OPM % | 4.3% | 15% | 26% | 10% | 16% | 14% | 15% | 15% | 11% | 14% | 13% | 12% | 11% |
| Other Income | 13 | -130 | -8 | 38 | 47 | 52 | 47 | 36 | 65 | 206 | 118 | 68 | 78 |
| Interest | 102 | 67 | 55 | 52 | 41 | 64 | 39 | 31 | 49 | 84 | 93 | 77 | 76 |
| Depreciation | 116 | 110 | 105 | 95 | 96 | 101 | 112 | 114 | 130 | 166 | 173 | 177 | 178 |
| PBT | -76 | 108 | 735 | 345 | 602 | 568 | 609 | 599 | 408 | 742 | 562 | 560 | 546 |
| Tax % | -24% | 7% | 19% | 33% | 4% | 9% | 21% | 22% | 30% | 28% | 22% | 32% | — |
| Net Profit | -58 | 100 | 593 | 232 | 576 | 519 | 480 | 465 | 284 | 534 | 437 | 378 | 371 |
| EPS in Rs | -2.37 | 4.09 | 25.23 | 10.14 | 25.21 | 23.61 | 22.85 | 22.77 | 14.09 | 26.49 | 21.64 | 18.74 | 18.28 |
| Div. Payout % | 0% | 0% | 14% | 25% | 10% | 11% | 11% | 11% | 18% | 11% | 14% | 19% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 23 | 23 | 22 | 21 | 20 | 20 | 20 | 20 | 20 |
| Reserves | 1,103 | 1,205 | 1,537 | 1,594 | 2,095 | 2,394 | 2,598 | 2,749 | 2,875 | 3,381 | 3,775 | 4,118 |
| Borrowings | 1,678 | 1,667 | 1,782 | 990 | 1,734 | 1,482 | 1,240 | 1,211 | 1,880 | 2,009 | 2,627 | 3,170 |
| Other Liabilities | 1,099 | 805 | 685 | 1,093 | 851 | 910 | 774 | 512 | 653 | 678 | 707 | 1,098 |
| Total Liabilities | 3,904 | 3,701 | 4,027 | 3,700 | 4,703 | 4,808 | 4,634 | 4,492 | 5,429 | 6,088 | 7,129 | 8,406 |
| Fixed Assets | 1,377 | 1,340 | 1,412 | 1,446 | 1,422 | 1,624 | 1,599 | 1,634 | 2,599 | 2,639 | 2,645 | 2,604 |
| CWIP | 8 | 86 | 6 | 11 | 46 | 12 | 14 | 204 | 24 | 46 | 106 | 1,747 |
| Investments | 41 | 48 | 74 | 122 | 166 | 244 | 249 | 173 | 263 | 339 | 431 | 468 |
| Other Assets | 2,479 | 2,226 | 2,535 | 2,121 | 3,070 | 2,927 | 2,772 | 2,482 | 2,543 | 3,064 | 3,947 | 3,587 |
| Total Assets | 3,904 | 3,701 | 4,027 | 3,700 | 4,703 | 4,808 | 4,634 | 4,492 | 5,429 | 6,088 | 7,129 | 8,406 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -76 | 147 | 346 | 1,180 | -523 | 850 | 649 | 695 | 453 | 178 | 425 | 599 |
| Investing | -23 | -147 | -117 | -159 | -159 | -305 | -81 | -309 | -859 | -225 | -880 | -947 |
| Financing | 38 | -70 | -233 | -1,020 | 682 | -546 | -569 | -385 | 406 | 47 | 455 | 347 |
| Net Cash Flow | -62 | -70 | -4 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -101 | -6 | 223 | 1,048 | -649 | 608 | 551 | 298 | -391 | -43 | -455 | -346 |
| CFO/OP | -50 | 40 | 54 | 286 | -57 | 139 | 98 | 115 | 100 | 35 | 70 | 96 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 26 | 17 | 15 | 38 | 18 | 19 | 10 | 10 | 8 | 10 | 10 |
| Inventory Days | 243 | 344 | 391 | 189 | 277 | 239 | 251 | 232 | 248 | 268 | 295 | 248 |
| Days Payable | 107 | 77 | 49 | 82 | 72 | 70 | 63 | 29 | 34 | 26 | 26 | 22 |
| Cash Conversion Cycle | 155 | 294 | 359 | 123 | 243 | 188 | 207 | 213 | 224 | 250 | 279 | 236 |
| Working Capital Days | 4 | 50 | 35 | 16 | 68 | 70 | 80 | 67 | 42 | 60 | 50 | 22 |
| ROCE % | 1% | 12% | 26% | 13% | 20% | 16% | 17% | 16% | 10% | 13% | 10% | 9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Balrampur Chini Mills insights
65 extracted metrics + investor summaries across FY11–FY27.
Documents
Frequently Asked Questions about Balrampur Chini Mills
What does Balrampur Chini Mills Ltd do?
Where is Balrampur Chini Mills Ltd (BALRAMCHIN) listed?
Which sector does Balrampur Chini Mills Ltd belong to?
What is the market capitalisation of Balrampur Chini Mills Ltd?
What is the PE ratio of Balrampur Chini Mills Ltd?
What is the 52-week high and low of Balrampur Chini Mills Ltd?
Does Balrampur Chini Mills Ltd pay dividends?
What is the Return on Equity (ROE) of Balrampur Chini Mills Ltd?
Company Information
Balrampur Chini Mills Limited (BCML) is one of the largest integrated sugar companies in India. The allied businesses of the Company comprise distillery operations and cogeneration of power.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BALRAMCHIN.md for Balrampur Chini Mills Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.